MAGLi 432
MAGLi 432 is a potent, selective, and reversible monoacylglycerol lipase (MAGL) inhibitor with low nanomolar IC50 values against human and mouse enzymes. Its ability to modulate the endocannabinoid system makes it a valuable research tool for in vitro and in vivo studies of neuroinflammation, neurodegeneration, and blood-brain barrier integrity in models of multiple sclerosis, Alzheimer's, and Parkinson's disease.
Product Specifications
CAS Number
2361575-20-2
Field of Research
Metabolism Research
Smiles
C (=O) (N1C[C@@]2 (N (C[C@H] (CC2) C3=CC=C (Cl) C=C3) CC1) [H]) C4=C (Br) C (OC) =CC=C4
Molecular Formula
C22H24BrClN2O2
Molecular Weight
463.8
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1480449-01 0.02 mg (E-Coli)
Recombinant Nocardia farcinica Imidazolonepropionase (hutI)
Sign In for Pricing
View Details MBS1480449-02 0.02 mg (Yeast)
Recombinant Nocardia farcinica Imidazolonepropionase (hutI)
Sign In for Pricing
View Details MBS1480449-03 0.1 mg (E-Coli)
Recombinant Nocardia farcinica Imidazolonepropionase (hutI)
Sign In for Pricing
View Details MBS1480449-04 0.1 mg (Yeast)
Recombinant Nocardia farcinica Imidazolonepropionase (hutI)
Sign In for Pricing
View Details MBS1480449-05 0.02 mg (Baculovirus)
Recombinant Nocardia farcinica Imidazolonepropionase (hutI)
Sign In for Pricing
View Details MBS1480449-06 0.02 mg (Mammalian-Cell)
Recombinant Nocardia farcinica Imidazolonepropionase (hutI)
Sign In for Pricing
View Details